Editorial Do You See What I See? Time for a Standardized Approach to Angiography-Based Decision Making Eric A. Osborn, MD, PhD; Donald E. Cutlip, MD There are 2 ways to be fooled. One is to believe what isn’t true; the other is to refuse to believe what is true. —Søren Kierkegaard (1813–1855)

T

he relative merit of percutaneous coronary intervention (PCI) for the treatment of stable ischemic heart disease remains a debated issue. Clinical trials that have relied mostly on a visual estimate of angiographic stenosis severity for subject selection have failed to demonstrate a clinical benefit for PCI when compared with guideline-directed medical therapy alone.1 Meanwhile, studies using a measure of coronary physiology, the fractional flow reserve (FFR), have not only confirmed a benefit for PCI in treatment of lesions assessed as hemodynamically significant (FFR≤0.80)2 but also shown the potential for unnecessary PCI and associated harm using a visual angiography-guided strategy.3 Indeed, the discordance between visual estimates and FFR is 65% for lesions judged to have 50% to 70% diameter stenosis and 20% even for those lesions judged to have 70% to 90% diameter stenosis.4 On the basis of available data, current consensus guidelines in the United States and Europe recommend FFR-guided PCI as class IIa and I indications, respectively.5 Likewise, the appropriate use criteria for coronary revascularization endorsed by multiple cardiovascular societies incorporate FFR measurements for assessment of borderline lesions.6

Article see p 751 Despite guideline recommendations, registry data on FFR assessment of intermediate stenoses indicate that only 6% of PCI are FFR guided, with the use limited mainly to academic teaching hospitals.7 In this issue of Circulation: Cardiovascular Interventions, Toth et al8 address some of the factors influencing FFR use. They report on an anonymous Web-based survey that aimed to evaluate the clinical decision-making strategies of ≈500 interventional cardiologists based on an assessment of intermediate severity stenoses in patients with stable ischemic heart disease. Participants were shown 5 angiograms with intermediate lesions, half of which were known to be functionally significant according to FFR≤0.80 and asked to estimate The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association. From the Cardiology Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA. Correspondence to Donald E. Cutlip, MD, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, MA 02215. E-mail dcutlip@ bidmc.harvard.edu (Circ Cardiovasc Interv. 2014;7:736-738.) © 2014 American Heart Association, Inc. Circ Cardiovasc Interv is available at http://circinterventions.ahajournals.org DOI: 10.1161/CIRCINTERVENTIONS.114.002082

the percentage diameter stenosis visually. Participants were then asked to determine whether each identified stenosis was significant. For visually nonsignificant lesions, they were given a choice of FFR, quantitative coronary angiography (QCA), or invasive imaging with intravascular ultrasound or optical coherence tomography to assess lesion significance further. Within the limitations of an anonymous survey tool, the study provides useful information on contemporary decision making for PCI. The results should be disappointing to the interventional cardiology community, given current guideline recommendations and the publicity surrounding the lack of benefit and potential harm of unnecessary PCI. More than 70% of decisions were made solely on the estimated visual interpretation. Referenced to the known lesion FFR values, the visual estimate was discordant ≈50% of the time. Nevertheless, survey participants were highly confident in their visually based decisions, including 27% that did not select FFR assessment for any of the intermediate lesions. Although increasing experience with FFR technology tended to influence FFR use positively, the most experienced group still only selected FFR in 28% of the cases, resulting in a rather small improvement in discordance between visual estimates and FFR (range, 49%–57%). The results are especially concerning because the survey method probably yields a best-case scenario, without the necessity for the respondents to consider any of the practical constraints to performing FFR in clinical practice. Thus, the responses may reflect more serious conceptual deficiencies within the practice of interventional cardiology, including problems with estimating lesion severity, belief that the visual estimate at the operator-specific threshold reflects true functional significance, or a lack of belief that functional significance is important for determining PCI appropriateness or outcomes. Each of these possibilities can be supported by the data from Toth et al8 and raise concern that operators and patients may be fooled by the angiographic interpretation into unnecessary, potentially harmful procedures. The question for our specialty is what we can do to improve decision making using both the anatomic and the physiological tools available.

Improving Operator Knowledge of FFR Principles The data from Toth et al8 suggest that FFR might be regarded as a correction for deficiencies in visual quantification by some operators, for which the study participants were clearly confident as reflected by infrequent consideration of the need for such correction. From a physics perspective, however, FFR measurements provide data on the effect of the stenosis on actual distal blood flow, being derived from the assumption that coronary blood flow is linearly related to the pressure beyond the stenosis at steady state under conditions of maximal blood

Downloaded from http://circinterventions.ahajournals.org/ by guest on January 19, 2015 736

Osborn and Cutlip   Revascularization and Intermediate Lesions   737 flow when vessel resistance is minimal.9 By comparing the ratio of the pressure distal to the stenosis (Pd) to the normal aortic reference pressure (Pa), FFR thus represents the reduction of blood flow in a stenotic artery compared with a normal vessel. A distal pressure decrement is influenced by multiple factors beyond lumen diameter, so FFR also accounts for the effects of longer length lesions, collateral flow, and larger size myocardial beds. Because most patients with PCI have geometrically complex, multifocal lesions, FFR supplies critical functional information on multiple lesion-specific factors simultaneously that cannot be understood or captured by the most accurate assessment of stenosis severity alone. Developing focused instructional tools to train operators in the fundamental principles behind FFR measurements may enhance physician understanding of the significance of FFR and translate into greater FFR use.

Improving FFR Use for Angiographic Intermediate Stenoses Given that angiography in isolation is unable to predict ischemia accurately and that a FFR-guided strategy decreases unnecessary PCI and improves outcomes, should FFR assessment be mandatory before PCI? And if so, what angiographic threshold should be used? A recent single-center experience that switched to routine FFR from usual practice sheds light on this matter, reporting that FFR use improved from 2% to 51%, resulting in more judicious stent implantation and a concomitant overall improvement in outcomes at 1 year.10 Although available data suggest benefit of FFR measurements even in stenoses estimated to be severe, the largest value is in intermediate stenoses ranging from 40% to 70%. Given the marked discordance between FFR and angiography for these intermediate lesions, mandatory use of FFR to determine PCI appropriateness seems reasonable as suggested by the appropriate use criteria.

Improving Individual Visual Angiographic Performance Despite the well-described limitations of the visual estimate of angiographic severity, it is highly likely that an initial visual estimate will remain the gateway for the treatment decisions. It is also likely that some threshold of stenosis in an appropriate vessel territory and clinical scenario will be acceptable for PCI to most observers. The appropriate use criteria suggests a visual estimate of 70% for this threshold.6 This is not perfect, of course, but if standardization of the visual estimates could be improved such that stenoses that are clearly

Do you see what I see? Time for a standardized approach to angiography-based decision making.

Do you see what I see? Time for a standardized approach to angiography-based decision making. - PDF Download Free
451KB Sizes 1 Downloads 7 Views